Evidence for differential responsiveness of human CD5+ and CD5- B cell subsets to T cell-independent mitogens
- PMID: 1705511
- DOI: 10.1002/eji.1830210216
Evidence for differential responsiveness of human CD5+ and CD5- B cell subsets to T cell-independent mitogens
Abstract
Tonsillar resting B cells were separated into CD5+ and CD5- cell subsets and stimulated with the thymus-independent mitogens, Staphylococcus aureus Cowan strain I (SAC) or insolubilized anti-mu monoclonal antibodies (a mu Ab). CD5+ cells incorporated [3H]thymidine more efficiently than unfractionated cells when stimulated with SAC and their response was augmented by the addition of interleukin (IL) 2 to the cultures. CD5+ cells also proliferated in response to a mu Ab provided that IL 2 was present, SAC-, but not a mu Ab-stimulated CD5+ cells produced IgM and IgG molecules when IL 2 was added to the cultures and also secreted autoantibodies with rheumatoid factor activity and sometimes also with anti-single-stranded, but not double-stranded, DNA activity. The efficient response of CD5+ cells was not explained by the fact that they contained cells already activated in vivo. Thus, they did not express the CD23, CD69, CD71 and CD39 activation markers, failed to incorporated [3H]thymidine and to secrete Ig spontaneously or in response to IL 2 and were found to be in a quiescent state by cell cycle flow cytometric analysis. In contrast to CD5+ cells, CD5- cells displayed very little or no [3H]thymidine incorporation in response to SAC or to a mu Ab and their poor responsiveness was not altered by changing either the doses of the stimulants, the timing of the cultures, by co-culturing the cells together with CD5+ cells, or by adding IL 2 or IL 4. Immunofluorescence studies showed that freshly prepared CD5- cells did not have surface activation markers but that they expressed them following SAC stimulation. Thus, unlike that observed for CD5+ cells, SAC seems to be capable of activating CD5- cells but does not appear to be a sufficient stimulus for driving the cells into the subsequent phases of the cell cycle. The above findings, that demonstrate marked differences in the response to CD5+ and CD5- cells to thymus-independent stimuli, may bear relevance for the understanding of the normal clonal expansion of CD5+ cells as well as for the pathogenesis of autoimmune diseases.
Similar articles
-
Identification of two distinct CD5- B cell subsets from human tonsils with different responses to CD40 monoclonal antibody.Eur J Immunol. 1993 Apr;23(4):873-81. doi: 10.1002/eji.1830230416. Eur J Immunol. 1993. PMID: 7681401
-
Proliferation and differentiation of human CD5+ and CD5- B cell subsets activated through their antigen receptors or CD40 antigens.Eur J Immunol. 1992 Nov;22(11):2831-9. doi: 10.1002/eji.1830221112. Eur J Immunol. 1992. PMID: 1385152
-
Expression of CD5 and CD38 by human CD5- B cells: requirement for special stimuli.Eur J Immunol. 1994 Jun;24(6):1426-33. doi: 10.1002/eji.1830240628. Eur J Immunol. 1994. PMID: 7515814
-
Regulation of growth and proliferation in B cell subpopulations.Immunol Rev. 1982;64:161-82. doi: 10.1111/j.1600-065x.1982.tb00423.x. Immunol Rev. 1982. PMID: 6806172 Review.
-
Lymphokine production by B cells from normal and HIV-infected individuals.Ann N Y Acad Sci. 1992 May 4;651:220-7. doi: 10.1111/j.1749-6632.1992.tb24617.x. Ann N Y Acad Sci. 1992. PMID: 1376041 Review.
Cited by
-
B cells in human lymphoid structures.Clin Exp Immunol. 2022 Dec 31;210(3):240-252. doi: 10.1093/cei/uxac101. Clin Exp Immunol. 2022. PMID: 36370126 Free PMC article. Review.
-
B cell receptors in TCL1 transgenic mice resemble those of aggressive, treatment-resistant human chronic lymphocytic leukemia.Proc Natl Acad Sci U S A. 2006 Aug 1;103(31):11713-8. doi: 10.1073/pnas.0604564103. Epub 2006 Jul 24. Proc Natl Acad Sci U S A. 2006. PMID: 16864779 Free PMC article.
-
Identification and analysis of a novel human surface CD5- B lymphocyte subset producing natural antibodies.J Immunol. 1992 May 1;148(9):2690-702. J Immunol. 1992. PMID: 1374094 Free PMC article.
-
Somatic diversification and selection of immunoglobulin heavy and light chain variable region genes in IgG+ CD5+ chronic lymphocytic leukemia B cells.J Exp Med. 1995 Apr 1;181(4):1507-17. doi: 10.1084/jem.181.4.1507. J Exp Med. 1995. PMID: 7535340 Free PMC article.
-
Chronic Lymphocytic Leukemia B-Cell Normal Cellular Counterpart: Clues From a Functional Perspective.Front Immunol. 2018 Apr 4;9:683. doi: 10.3389/fimmu.2018.00683. eCollection 2018. Front Immunol. 2018. PMID: 29670635 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials